Trade Mark Journal No.2025/031 1 August 2025

WO0000001863768 (5,35,42,44)

Office of origin: United States of America

Date of International Registration:25 April 2025
Date of designation in the UK: 25 April 2025
Image for mark 1863768

The mark consists of the stylized wording "CURADEL PHARMA", to the left of which is a shaded circle surrounded by three shaded, curved lines extending in opposite directions.

Class 5
Contrast agents for use in surgical and medical imaging and visualization; fluorescent contrast agents for use in surgical and medical imaging and visualization; exogenous contrast agents for use in surgical and medical imaging and visualization; near-infrared contrast agents for use in surgical and medical imaging and visualization; exogenous near-infrared contrast agents for use in surgical and medical imaging and visualization; near-infrared contrast agents for use in surgical procedures; exogenous near-infrared contrast agents for use in surgical procedures; near-infrared contrast agents for use in medical imaging and visualization; exogenous near-infrared contrast agents for use in medical imaging and visualization; near-infrared contrast agents for use in real-time surgical imaging and visualization; exogenous near-infrared contrast agents for use in real-time surgical imaging and visualization; none of the foregoing being ophthalmic preparations, otorhinolaryngological preparations, or preparations for the treatment of inflammation.
Class 35
Providing consumer information in the field of cancer treatment and diagnosis via the Internet and social media.
Class 42
Medical and scientific research services in the field of cancer treatment and diagnosis.
Class 44
Providing health information in the field of cancer treatment and diagnosis via the Internet and social media.

Curadel Surgical Innovations, Inc.

Representative: Gregory N. Brescia Gordon & Rees LLP, 500 Mamaroneck Ave, Suite 503, Harrison NY 10528, UNITED STATES OF AMERICA